ProductsJohnson & Johnson

Johnson & Johnson product analyses

A tighter look at the products that matter most to Johnson & Johnson, along with the free, open, decentralized, or cooperative alternatives already creating pricing pressure and the original disruption concepts that could widen that pressure further.

Products

Where the moat actually touches users

These pages zoom into the products and services that matter most to each company, the alternatives already nibbling at them, and 2 structured disruption concepts across the current product set.

2 disruption concepts tracked0 documented exceptions

Innovative Medicine portfolio

pharmaceuticals

1 concept

Johnson & Johnson's Innovative Medicine segment spans oncology, immunology, neuroscience, and cardiopulmonary therapies, with multiple blockbuster products and a large late-stage pipeline.

Open analysis

MedTech portfolio

medical-devices

1 concept

Johnson & Johnson's MedTech segment covers cardiovascular intervention, surgery, robotics, wound closure, and vision products sold into clinician and hospital workflows.

Open analysis

Paper trail